A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C

Clinical trial NCT02621892 · COMPLETED

Trial details

NCT number: NCT02621892
Sponsor: Ardelyx
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Constipation Predominant Irritable Bowel Syndrome

Start date: 2015-10-01
Primary completion: 2017-03-01
Enrollment: 606

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.